Xuebing Feng

5.9k total citations
142 papers, 4.3k citations indexed

About

Xuebing Feng is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Xuebing Feng has authored 142 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Rheumatology, 58 papers in Immunology and 41 papers in Genetics. Recurrent topics in Xuebing Feng's work include Systemic Lupus Erythematosus Research (65 papers), Mesenchymal stem cell research (37 papers) and Systemic Sclerosis and Related Diseases (19 papers). Xuebing Feng is often cited by papers focused on Systemic Lupus Erythematosus Research (65 papers), Mesenchymal stem cell research (37 papers) and Systemic Sclerosis and Related Diseases (19 papers). Xuebing Feng collaborates with scholars based in China, United States and Hong Kong. Xuebing Feng's co-authors include Lingyun Sun, Dandan Wang, Huayong Zhang, Jun Liang, Bingzhu Hua, Genhong Yao, Liwei Lu, Xia Li, Betty P. Tsao and Gary S. Gilkeson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Xuebing Feng

131 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuebing Feng China 38 1.8k 1.4k 1.4k 1.3k 531 142 4.3k
Simone Negrini Italy 29 1.0k 0.6× 1.3k 0.9× 410 0.3× 612 0.5× 625 1.2× 88 3.6k
Kazuhisa Nakano Japan 35 491 0.3× 1.3k 0.9× 1.6k 1.1× 879 0.7× 231 0.4× 137 3.7k
Wolf‐Karsten Hofmann Germany 42 1.9k 1.0× 1.1k 0.8× 682 0.5× 2.9k 2.3× 735 1.4× 251 6.7k
Hitoshi Okochi Japan 36 1.1k 0.6× 942 0.7× 462 0.3× 3.1k 2.4× 1.2k 2.4× 108 6.3k
Benedetta Mazzinghi Italy 30 1.5k 0.9× 2.9k 2.0× 316 0.2× 2.6k 2.1× 1.3k 2.4× 55 7.4k
Patricia Luz‐Crawford Chile 26 1.3k 0.7× 803 0.6× 306 0.2× 1.2k 1.0× 498 0.9× 61 3.0k
Cesare Danesino Italy 40 1.1k 0.6× 753 0.5× 503 0.4× 874 0.7× 858 1.6× 176 4.8k
Benjamin H. Lee United States 34 2.1k 1.2× 722 0.5× 757 0.5× 3.4k 2.7× 300 0.6× 70 6.2k
George Bou–Gharios United Kingdom 44 834 0.5× 578 0.4× 509 0.4× 3.4k 2.7× 995 1.9× 158 6.6k
Arjen B. Blom Netherlands 38 438 0.2× 1.1k 0.8× 3.0k 2.2× 1.9k 1.5× 621 1.2× 93 4.8k

Countries citing papers authored by Xuebing Feng

Since Specialization
Citations

This map shows the geographic impact of Xuebing Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebing Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebing Feng more than expected).

Fields of papers citing papers by Xuebing Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebing Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebing Feng. The network helps show where Xuebing Feng may publish in the future.

Co-authorship network of co-authors of Xuebing Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebing Feng. A scholar is included among the top collaborators of Xuebing Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebing Feng. Xuebing Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jing, Xuebing Feng, Jiayun Pang, et al.. (2025). Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing. BMC Infectious Diseases. 25(1). 335–335.
2.
Gao, Peng, Xiaoxin He, Haibo Wang, et al.. (2025). Stenting Versus Medical Therapy for Symptomatic Intracranial Artery Stenosis: Long-Term Follow-Up of a Randomized Trial. Stroke. 56(5). 1128–1137.
3.
Ren, Qian, Ruoxi Li, Xiaojun Liu, et al.. (2025). Epidemiological Trends and Predictive Modeling of Dengue Fever in the Association of Southeast Asian Nations (ASEAN) Countries. Tropical Medicine and Infectious Disease. 10(12). 329–329.
4.
Wang, Dandan, Xiaobing Wang, Binghe Tan, et al.. (2025). Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission. Med. 6(10). 100749–100749. 8 indexed citations
5.
6.
Xu, Xuefeng, et al.. (2025). Transbronchial lung cryobiopsy for diagnosing interstitial lung disease: a cross-sectional, comparative study. European journal of medical research. 30(1). 171–171.
7.
Jiang, Xiaoman, et al.. (2025). Metabolomic analysis suggests thiamine monophosphate as a potential marker for mesenchymal stem cell transplantation outcomes in patients with SLE. Lupus Science & Medicine. 12(1). e001197–e001197. 3 indexed citations
8.
Feng, Xuebing, Tongyu Zhang, Ning Wang, et al.. (2024). Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial. Stroke and Vascular Neurology. 9(5). 530–540. 7 indexed citations
9.
Tang, Xiaojun, Wei Shen, Jun Liang, et al.. (2024). Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients. BMC Rheumatology. 8(1). 68–68.
10.
Zhang, Dongdong, Hongzhen Chen, Dan Wu, et al.. (2024). Immune profiling analysis of double-negative T cells in patients with systemic sclerosis. Clinical Rheumatology. 43(5). 1623–1634. 2 indexed citations
11.
Xu, Xuefeng, Genhong Yao, Dandan Wang, et al.. (2024). Risk factors for initial and recurrent severe infections in first hospitalized patients with systemic lupus erythematosus: A retrospective study of a Chinese cohort. International Journal of Rheumatic Diseases. 27(4). e15131–e15131. 2 indexed citations
12.
Li, Qi, et al.. (2024). Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study. Journal of clinical lipidology. 18(6). e968–e976. 3 indexed citations
13.
Liang, Jun, Genhong Yao, Linyu Geng, et al.. (2023). Factors associated with 25-hydroxyvitamin D level in Chinese hospitalized patients with systemic lupus erythematosus: a retrospective cohort study. Rheumatology International. 44(10). 2067–2078. 1 indexed citations
14.
Jin, Ziyi, Zheng Chen, Wenyou Pan, et al.. (2023). Comparison of Contributors to Mortality Differences in SLE Patients with Different Initial Disease Activity: A Larger Multicenter Cohort Study. Journal of Clinical Medicine. 12(3). 1061–1061. 2 indexed citations
15.
Zhang, Xueyi, Jun Liang, Genhong Yao, et al.. (2023). Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case–Control Study. Rheumatology and Therapy. 10(6). 1535–1554. 4 indexed citations
16.
Zhao, Cheng, Lu Zhang, Wei Kong, et al.. (2015). Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Journal of Immunology Research. 2015. 1–10. 42 indexed citations
17.
Feng, Xuebing, Fei Gu, Weiwei Chen, et al.. (2014). Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis. Chinese Medical Journal. 127(21). 3718–3723. 17 indexed citations
18.
Zhu, Yun, Jing Wang, & Xuebing Feng. (2014). CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and Systemic Lupus Erythematosus: A Meta-Analysis. Critical Reviews in Eukaryotic Gene Expression. 24(2). 89–100. 7 indexed citations
19.
Feng, Xuebing, Wenyou Pan, Min Wu, et al.. (2011). Prognostic Indicators of Hospitalized Patients with Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study in China. The Journal of Rheumatology. 38(7). 1289–1295. 43 indexed citations
20.
Zhang, Huayong, et al.. (2008). Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL/lpr Mice. Cellular and Molecular Immunology. 5(6). 417–424. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Negrini Breakdown of academic impact, for papers by Kazuhisa Nakano Breakdown of academic impact, for papers by Wolf‐Karsten Hofmann Breakdown of academic impact, for papers by Hitoshi Okochi Breakdown of academic impact, for papers by Benedetta Mazzinghi Breakdown of academic impact, for papers by Patricia Luz‐Crawford Breakdown of academic impact, for papers by Cesare Danesino Breakdown of academic impact, for papers by Benjamin H. Lee Breakdown of academic impact, for papers by George Bou–Gharios Breakdown of academic impact, for papers by Arjen B. Blom
Rankless by CCL
2026